ストックスクリーナーアプリを入手
31.64
3.47%
-0.95
Eton Pharmaceuticals Inc (ETON) 最新ニュース
ETON SEC FilingsEton Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
H.C. Wainwright Remains Bullish on Eton Pharmaceuticals’ (ETON) Growth Strategy - Insider Monkey
Eton Pharmaceuticals Inc (ETON) Shares Fall 6.9% -- GF Value Says Still Overvalued - GuruFocus
ETON (Nasdaq) Rule 144 shows RSUs and Options grants dated 2024–2026 - Stock Titan
5 Oversold Growth Stocks to Invest In Now - Insider Monkey
H.C. Wainwright reiterates Eton Pharmaceuticals stock rating at buy By Investing.com - Investing.com Canada
Earnings call transcript: Eton Pharmaceuticals Q1 2026 shows mixed results By Investing.com - Investing.com Nigeria
Earnings call transcript: Eton Pharmaceuticals Q1 2026 shows mixed results - Investing.com
Eton Pharmaceuticals (ETON) soars 6.7%: Is further upside left in the stock? - MSN
Eton Pharmaceuticals, Inc.Common Stock (NQ: ETON - The Chronicle-Journal
Eton Pharmaceuticals acquires U.S. rights to leishmaniasis drug By Investing.com - Investing.com South Africa
Eton Pharmaceuticals acquires U.S. rights to leishmaniasis drug - Investing.com
Eton Pharmaceuticals Obtains US Commercialization Rights to Impavido - Moomoo
Eton (NASDAQ: ETON) licenses U.S. IMPAVIDO rights in rare disease push - Stock Titan
Eton Pharmaceuticals Announces U.S. Commercialization Rights for IMPAVIDO®, First FDA-Approved Oral Therapy for Leishmaniasis - Quiver Quantitative
Eton Pharmaceuticals Expands Rare Disease Portfolio Through - GlobeNewswire
Price-Driven Insight from (ETON) for Rule-Based Strategy - Stock Traders Daily
H.C. Wainwright raises Eton Pharmaceuticals stock price target to $57 By Investing.com - Investing.com Canada
Eton Pharmaceuticals, Inc. Just Missed EPS By 44%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2026 Earnings Call Transcript - Insider Monkey
Eton Pharmaceuticals Q1 Non-GAAP EPS, Revenue Rise - Moomoo
Eton Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Eton projects revenue to exceed $120M in 2026 as it targets a 50% adjusted EBITDA margin by 2028 - MSN
Eton Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
MSN Money - MSN
Eton Pharmaceuticals, Inc. (ETON) misses Q1 earnings estimates - MSN
ETON: Record Q1 sales and new product launches drive raised 2026 revenue guidance above $120 million - TradingView
Eton Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Eton Pharmaceuticals Q1 2026 revenue beats, EPS misses - Investing.com
Eton Pharmaceuticals earnings missed by $0.14, revenue topped estimates - Investing.com
Eton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimates - Yahoo Finance
Full Transcript: Eton Pharmaceuticals Q1 2026 Earnings Call - Benzinga
ETON PHARMACEUTICALS ($ETON) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Eton Pharmaceuticals (ETON) swings to Q1 2026 profit as rare disease sales grow - Stock Titan
Surging sales turn Eton Pharmaceuticals (NASDAQ: ETON) profitable in Q1 2026 - Stock Titan
Earnings Flash (ETON) Eton Pharmaceuticals, Inc. Posts Q1 Adjusted EPS $0.14 per Share, vs. FactSet Est of $0.14 - marketscreener.com
Earnings Flash (ETON) Eton Pharmaceuticals, Inc. Reports Q1 Revenue $24.3M, Vs. FactSet Est of $22.3M - Moomoo
Press Release: Eton Pharmaceuticals Reports First Quarter 2026 Financial Results - Moomoo
Does Eton Pharmaceuticals (ETON) have the potential to rally 49.25% as Wall Street analysts expect? - MSN
Eton Pharmaceuticals Q1 2026 earnings preview - MSN
Eton Pharmaceuticals raises 2026 revenue forecast after Q1 sales jump 73% and new product launches. - Pluang
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
1.38%
1.89%
大文字化:
|
ボリューム (24 時間):